×
Back to Agenda
Automation in Pharmacovigilance: Doing More with Less
Session Chair(s)
Axel Hagel
Practice Leader, PV & RM Services, , IQVIA, United States
The session will provide an overview of the current pharmacovigilance landscape and where the industry stands on automation versus manual processes with respect to adverse event processing, assessing, reporting and signaling. Functional areas will then be presented where companies can employ simple to sophisticated means to automate many of the resource intensive processes that will result in better consistency, higher quality and improved compliance.
Learning Objective : Identify functions or processes that could benefit from improvements within their own pharmacovigilance practice especially through methods of automation; Explain how companies have successfully automated many aspects of the PV process and the benefits as well as liabilities such an automation can bring.
Speaker(s)
Masha Hoffey, MS
Director of Clinical Analytics, PerkinElmer Informatics, Inc., United States
Neal Grabowski, MBA, MS
TransCelerate IAO Workstream Lead; Head, Signal Management, Sanofi, United States
Have an account?